{
    "eid": "2-s2.0-84928570317",
    "title": "Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation",
    "cover-date": "2015-05-01",
    "subject-areas": [
        {
            "$": "Hepatology",
            "@code": "2721"
        },
        {
            "$": "Transplantation",
            "@code": "2747"
        },
        {
            "$": "Surgery",
            "@code": "2746"
        }
    ],
    "keywords": [],
    "authors": [
        "Roongruedee Chaiteerakij"
    ],
    "citedby-count": 101,
    "ref-count": 18,
    "ref-list": [
        "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012",
        "Management of hepatocellular carcinoma: An update",
        "Recurrence of hepatocellular carcinoma following liver transplantation: A review of preoperative and postoperative prognostic indicators",
        "Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis",
        "Recommendations for liver transplantation for hepatocellular carcinoma: An international consensus conference report",
        "Systematic review: The prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma",
        "Pretransplantation \u03b1-fetoprotein slope and milan criteria: Strong predictors of hepatocellular carcinoma recurrence after transplantation",
        "Significance of Des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma",
        "Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma",
        "Liver transplantation for hepatocellular carcinoma: A model including \u03b1-fetoprotein improves the performance of milan criteria",
        "Update on Biomarkers of Hepatocellular Carcinoma",
        "Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation",
        "The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma - With special reference to the serum levels of des-gamma-carboxy prothrombin",
        "Modified recist (mRECIST) assessment for hepatocellular carcinoma",
        "Recurrence of hepatocellular carcinoma: Importance of mRECIST response to chemoembolization and tumor size",
        "Des-\u03b3-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration",
        "Clinical evaluation of lens culinaris agglutinin-reactive \u03b1-fetoprotein and des-\u03b3-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States",
        "Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: A meta-analysis of observational studies"
    ],
    "affiliation": [
        {
            "affiliation-city": "Jacksonville",
            "affilname": "Mayo Clinic in Jacksonville, Florida",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic College of Medicine and Science",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic Cancer Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Rochester",
            "affilname": "Mayo Clinic",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Mountain View",
            "affilname": "Wako Life Sciences, Inc.",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Mayo Foundation for Medical Education and Research",
        "National Institutes of Health",
        "National Center for Advancing Translational Sciences",
        "National Center for Advancing Translational Sciences"
    ]
}